Search research articles
Contact Us
Filters
Showing results (291-300 of 338) with videos related to
Page
of 34
Sort By:
British Heart Journal
|
November 1, 1985
Bleeding complications of intracoronary fibrinolytic therapy in acute myocardial infarction. Assessment of risk in a randomised trial
F W Verheugt, M J van Eenige, J C Res, et al.
Catheterization and Cardiovascular Diagnosis
|
July 1, 1987
Value of immediate coronary angioplasty following intracoronary thrombolysis in acute myocardial infarction
H Suryapranata, P W Serruys, F Vermeer, et al.
Journal of the American College of Cardiology
|
August 1, 1996
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients
E D Peterson, W R Hathaway, K M Zabel, et al.
Journal of the American College of Cardiology
|
April 1, 1986
Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival
M L Simoons, P W Serruys, M van den Brand, et al.
European Heart Journal
|
August 1, 1988
Improvement of myocardial perfusion after thrombolysis assessed by thallium-201 exercise scintigraphy. Report of the Working Group on Thrombolytic Therapy in Acute Myocardial Infarction of the Netherlands Interuniversity Institute of Cardiology
E E van der Wall, J C Res, R van den Pol, et al.
Journal of the American College of Cardiology
|
June 1, 1996
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators
L K Newby, W R Rutsch, R M Califf, et al.
European Heart Journal
|
September 21, 2002
Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction
E Ronner, R T van Domburg, M J B M van den Brand, et al.
European Heart Journal
|
December 5, 2000
Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study
K M Akkerhuis, K L Neuhaus, R G Wilcox, et al.
Circulation
|
November 15, 1995
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries
J M Gore, C B Granger, M L Simoons, et al.
Cardiology
|
April 26, 2006
Which factors are associated with the application of reperfusion therapy in ST-elevation acute coronary syndromes?. Lessons from the Euro Heart Survey on Acute Coronary Syndromes I
R Nieuwlaat, M Lenzen, H J G M Crijns, et al.
Page
of 34
Search research articles
Search
Showing results (291-300 of 338) with videos related to
Sort By:
Page
of 34
British Heart Journal
|
November 1, 1985
Bleeding complications of intracoronary fibrinolytic therapy in acute myocardial infarction. Assessment of risk in a randomised trial
F W Verheugt, M J van Eenige, J C Res, et al.
Catheterization and Cardiovascular Diagnosis
|
July 1, 1987
Value of immediate coronary angioplasty following intracoronary thrombolysis in acute myocardial infarction
H Suryapranata, P W Serruys, F Vermeer, et al.
Journal of the American College of Cardiology
|
August 1, 1996
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients
E D Peterson, W R Hathaway, K M Zabel, et al.
Journal of the American College of Cardiology
|
April 1, 1986
Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival
M L Simoons, P W Serruys, M van den Brand, et al.
European Heart Journal
|
August 1, 1988
Improvement of myocardial perfusion after thrombolysis assessed by thallium-201 exercise scintigraphy. Report of the Working Group on Thrombolytic Therapy in Acute Myocardial Infarction of the Netherlands Interuniversity Institute of Cardiology
E E van der Wall, J C Res, R van den Pol, et al.
Journal of the American College of Cardiology
|
June 1, 1996
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators
L K Newby, W R Rutsch, R M Califf, et al.
European Heart Journal
|
September 21, 2002
Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction
E Ronner, R T van Domburg, M J B M van den Brand, et al.
European Heart Journal
|
December 5, 2000
Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study
K M Akkerhuis, K L Neuhaus, R G Wilcox, et al.
Circulation
|
November 15, 1995
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries
J M Gore, C B Granger, M L Simoons, et al.
Cardiology
|
April 26, 2006
Which factors are associated with the application of reperfusion therapy in ST-elevation acute coronary syndromes?. Lessons from the Euro Heart Survey on Acute Coronary Syndromes I
R Nieuwlaat, M Lenzen, H J G M Crijns, et al.
Page
of 34